• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Mol Struct . Anti-COVID-19 terpenoid from marine sources: a docking, ADMET and molecular dynamics study

tetano

Editor, Senior Moderator
J Mol Struct


. 2020 Oct 10;129433.
doi: 10.1016/j.molstruc.2020.129433. Online ahead of print.
Anti-COVID-19 terpenoid from marine sources: a docking, ADMET and molecular dynamics study


Nayim Sepay[SUP] 1 [/SUP], Aishwarya Sekar[SUP] 2 [/SUP], Umesh C Halder[SUP] 1 [/SUP], Abdullah Alarifi[SUP] 3 [/SUP], Mohd Afzal[SUP] 3 [/SUP]



Affiliations
Free PMC article

Abstract

Traditional medicines contain natural products (NPs) as main ingredient which always give new direction and paths to develop new advanced medicines. In the COVID-19 pandemic, NPs can be used or can help to find new compound against it. The SARS coronavirus-2 main protease (SARS CoV-2 M[SUP]pro[/SUP]) enzyme, arbitrate viral replication and transcription, is target here. The study show that, from the electronic features and binding affinity of all the NPs with the enzyme, the compounds with higher hydrophobicity and lower flexibility can be more favorable inhibitor. More than fifty NPs were screened for the target and one terpenoid (T3) from marine sponge Cacospongia mycofijiensis shows excellent SARS CoV-2 M[SUP]pro[/SUP] inhibitory activity in comparison with known peptide based inhibitors. The molecular dynamics simulation studies of the terpenoids with the protein indicates that the complex is stable and hydrogen bonds are involved during the complexation. Considering binding affinity, bioavailability, pharmacokinetics and toxicity of the compounds, it is proposed that the NP T3 can act as a potential drug candidate against COVID-19 virus.

Keywords: ADME; AR, Androgen Receptor; AR-LBD, Androgen Receptor Ligand Binding Domain; ATAD5, ATPase family AAA domain-containing protein 5; AhR, Aryl hydrocarbon Receptor; Docking; ER, Estrogen Receptor Alpha; ER-LBD, Estrogen Receptor Ligand Binding Domain; HSE, Heat shock factor response element; MMP, Mitochondrial Membrane Potential; Molecular Dynamics; Natural Products; PPAR-Gamma, Peroxisome Proliferator Activated Receptor Gamma; SARS CoV-2 Mpro; SARS, Severe acute respiratory syndrome; Toxicity; cyto, Cytotoxicity; dili, Hepatotoxicity carcino Carcinogenicity; mutagen, Mutagenicity; nrf2/ARE, Nuclear factor (erythroid-derived 2)-like 2/antioxidant responsive element.
 
Back
Top Bottom